2000Chinese Journal of Thoracic and Cardiovaescular SurgeryRequires access

A study of serum vascular endothelial growth factor in patients with congenital heart disease associated with pulmonary hypertension

WU Zhongsh

Open publisher page 0 citations

Abstract

Objective To investigate the relationship between development pulmonary hypertension and vascular endothelial growth factor(VEGF). Method Serum VEGF concentration was measured by using enzyme linked immunosorbent assay. In 23 patients with pulmonary hypertension [mean pulmonary artery pressure was (38 70±10 82)?mm?Hg] and 28 patients without pulmonary hypertension [mean pulmonary artery pressure was (16 42±2 03)mm?Hg].Results Mean concentration of serum VEGF in patients with pulmonary hypertension was (291 70±197 66)?pg/ml, and (38 56±22 25)?pg/ml in patients without pulmonary hypertension. VEGF concentration and pulmonary artery pressure were positively correlated(r=0 714,4). Conclusion The serum VEGF concentration in patients with congenital heart disease associated with pulmonary hypertension is much higher than that in control group (P0 01). VEGF is probably involved in the pathophysiology of pulmonary hypertension.

About this research paper

What this paper is about

Objective To investigate the relationship between development pulmonary hypertension and vascular endothelial growth factor(VEGF). Method Serum VEGF concentration was measured by using enzyme linked immunosorbent assay. In 23 patients with pulmonary hypertension [mean pulmonary artery pressure was (38 70±10 82)?mm?Hg] and 28 patients without pulmonary hypertension [mean pulmonary artery pressure was (16 42±2 03)mm?Hg].Results Mean concentration of serum VEGF in patients with pulmonary hypertension was (291 70±197 66)?pg/ml, and (38 56±22 25)?pg/ml in patients without pulmonary hypertension. VEGF concentration and pulmonary artery pressure were positively correlated(r=0 714,4). Conclusion The serum VEGF concentration in patients with congenital heart disease associated with pulmonary hypertension is much higher than that in control group (P0 01). VEGF is probably involved in the pathophysiology of pulmonary hypertension.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the relationship between development pulmonary hypertension and vascular endothelial growth factor(VEGF). Method Serum VEGF concentration was measured by using enzyme linked immunosorbent assay. In 23 patients with pulmonary hypertension [mean pulmonary artery pressure was (38 70±10 82)?mm?Hg] and 28 patients without pulmonary hypertension [mean pulmonary artery pressure was (16 42±2 03)mm?Hg].Results Mean concentration of serum VEGF in patients with pulmonary hypertension was (291 70±197 66)?pg/ml, and (38 56±22 25)?pg/ml in patients without pulmonary hypertension. VEGF concentration and pulmonary artery pressure were positively correlated(r=0 714,4). Conclusion The serum VEGF concentration in patients with congenital heart disease associated with pulmonary hypertension is much higher than that in control group (P0 01). VEGF is probably involved in the pathophysiology of pulmonary hypertension.

Key concepts: Medicine, Pulmonary hypertension, Pulmonary artery, Internal medicine, Pathophysiology, Cardiology, Vascular endothelial growth factor, Pathophysiology of hypertension

Related papers

Back to paper searchBrowse research topicsOriginal source
A study of serum vascular endothelial growth factor in patients with congenital heart disease associated with pulmonary hypertension — Research Paper | ScholarLens